Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Marriott

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Antiviral Research|October 9, 2012
Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivirNigel J Dimmock, Brian K Dove, Bo Meng, et al.
Plos One|December 20, 2012
Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be establishedNigel J Dimmock, Brian K Dove, Paul D Scott, et al.
Gene Therapy|September 26, 2001
Mucus altering agents as adjuncts for nonviral gene transfer to airway epitheliumS Ferrari, C Kitson, R Farley, et al.
NPJ Vaccines|March 30, 2021
Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccineAnthony C Marriott, Karen E Gooch, Phillip J Brown, et al.
Scientific Reports|June 25, 2016
Evolution of 2009 H1N1 influenza viruses during the pandemic correlates with increased viral pathogenicity and transmissibility in the ferret modelAnna Otte, Anthony C Marriott, Carola Dreier, et al.
Vaccine|December 1, 1996
Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virusK P Tolley, A C Marriott, A Simpson, et al.
The Journal of Infectious Diseases|December 11, 2021
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung PathologyKathryn A Ryan, Katarzyna E Schewe, Jonathan Crowe, et al.
Plos One|April 9, 2014
Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivirAnthony C Marriott, Brian K Dove, Catherine J Whittaker, et al.
Journal of Clinical Microbiology|November 1, 2019
Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical Respiratory SamplesKuiama Lewandowski, Yifei Xu, Steven T Pullan, et al.
Plos One|June 17, 2016
Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of InfectionAnthony C Marriott, Mike Dennis, Jennifer A Kane, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Antiviral Research|October 9, 2012
Comparison of the protection of ferrets against pandemic 2009 influenza A virus (H1N1) by 244 DI influenza virus and oseltamivirNigel J Dimmock, Brian K Dove, Bo Meng, et al.
Plos One|December 20, 2012
Cloned defective interfering influenza virus protects ferrets from pandemic 2009 influenza A virus and allows protective immunity to be establishedNigel J Dimmock, Brian K Dove, Paul D Scott, et al.
Gene Therapy|September 26, 2001
Mucus altering agents as adjuncts for nonviral gene transfer to airway epitheliumS Ferrari, C Kitson, R Farley, et al.
NPJ Vaccines|March 30, 2021
Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccineAnthony C Marriott, Karen E Gooch, Phillip J Brown, et al.
Scientific Reports|June 25, 2016
Evolution of 2009 H1N1 influenza viruses during the pandemic correlates with increased viral pathogenicity and transmissibility in the ferret modelAnna Otte, Anthony C Marriott, Carola Dreier, et al.
Vaccine|December 1, 1996
Identification of mutations contributing to the reduced virulence of a modified strain of respiratory syncytial virusK P Tolley, A C Marriott, A Simpson, et al.
The Journal of Infectious Diseases|December 11, 2021
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung PathologyKathryn A Ryan, Katarzyna E Schewe, Jonathan Crowe, et al.
Plos One|April 9, 2014
Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivirAnthony C Marriott, Brian K Dove, Catherine J Whittaker, et al.
Journal of Clinical Microbiology|November 1, 2019
Metagenomic Nanopore Sequencing of Influenza Virus Direct from Clinical Respiratory SamplesKuiama Lewandowski, Yifei Xu, Steven T Pullan, et al.
Plos One|June 17, 2016
Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of InfectionAnthony C Marriott, Mike Dennis, Jennifer A Kane, et al.
Pageof 15